Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Anti–protamine-heparin antibodies: incidence,...
Journal article

Anti–protamine-heparin antibodies: incidence, clinical relevance, and pathogenesis

Abstract

Protamine, which is routinely used after cardiac surgery to reverse the anticoagulant effects of heparin, is known to be immunogenic. Observing patients with an otherwise unexplained rapid decrease in platelet count directly after protamine administration, we determined the incidence and clinical relevance of protamine-reactive antibodies in patients undergoing cardiac-surgery. In vitro, these antibodies activated washed platelets in a …

Authors

Bakchoul T; Zöllner H; Amiral J; Panzer S; Selleng S; Kohlmann T; Brandt S; Delcea M; Warkentin TE; Sachs UJ

Journal

Blood, Vol. 121, No. 15, pp. 2821–2827

Publisher

American Society of Hematology

Publication Date

April 11, 2013

DOI

10.1182/blood-2012-10-460691

ISSN

0006-4971